MUMBAI, India, Sept. 26 -- Intellectual Property India has published a patent application (202517084420 A) filed by E-Therapeutics Plc, London, on Sept. 5, for 'inhibitors of expression and/or function.'
Inventor(s) include Whitmore, Alan Victor; Malandraki-Miller, Sophia; De Santiago, Ines; Pursell, Natalie; and Giannoustas, Gaye Saginc.
The application for the patent was published on Sept. 26, under issue no. 39/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to inhibitors, and compositions containing inhibitors, and uses of the same in the treatment or prevention of a metabolic disease or disorder, such as a metabolic disease or disorder associated with non-alcoholic fatty liver disease (NAFLD), and/or obesity and/or a disease or disorder associated with adipogenesis."
The patent application was internationally filed on Feb. 06, 2024, under International application No.PCT/EP2024/052934.
Disclaimer: Curated by HT Syndication.
